Nature Medicine.
MYC targeting by OMO-103 in solid tumors: a phase 1 trial.
npj Microgravity.
Explainable machine learning identifies multi-omics signatures of muscle response to spaceflight in mice.
bioRxiv.
Using LLM Models and Explainable ML to Analyse Biomarkers at Single Cell Level for Improved Understanding of Diseases.
Nature Mental Health.
Plasma proteomics discovery of mental health risk biomarkers in adolescents.
NASA GeneLab 2023 AWG Symposium: The year of open science.
Abzu’s Jonas Elsborg presents his research with NASA GeneLab: “Elucidating dermatological changes in spaceflight with explainable AI.”
The TOLAC project.
The TOLAC project brings data-driven insights to expectant parents at important stages of pregnancy to reduce the risk inherent in vaginal or caesarian delivery.
Abzu® selected partner for EU project Elegant North to create a new strategy for handling data on rare diseases.
To address the deficiency of treatments for rare diseases, the selected partners in project Elegant North will create a cross-border, rare disease data-sharing platform to foster cross-sector collaboration between researchers, companies, and healthcare systems.
Cancer Genetics.
Quantum lattices for early cancer detection through machine learning.
Journal of Gastroenterology and Hepatology.
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.
Intelligent Health AI
The world’s leading AI-in-medicine summit series. Connecting 200,000 clinicians, technologists, and C-suite executives.